Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Title of Study: SAcral Chordoma: a Randomized & Observational Study on Surgery Versus Definitive Radiation Therapy in Primary Localized Disease (SACRO)

NCT02986516 is registered in ClinicalTrials.gov with Italian Sarcoma Group as lead sponsor.

NCT NCT02986516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02986516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Title of Study: SAcral Chordoma: a Randomized & Observational Study on Surgery Versus Definitive Radiation Therapy in Primary Localized Disease (SACRO)
Lead sponsor
Italian Sarcoma Group
Phase
Not applicable
Overall status
Recruiting
Start date
March 16, 2017
Completion date
December 31, 2026
Enrollment
100 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

chordoma